1. Home
  2. ADNT vs GRAL Comparison

ADNT vs GRAL Comparison

Compare ADNT & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADNT
  • GRAL
  • Stock Information
  • Founded
  • ADNT 2016
  • GRAL 2016
  • Country
  • ADNT Ireland
  • GRAL United States
  • Employees
  • ADNT N/A
  • GRAL N/A
  • Industry
  • ADNT Auto Parts:O.E.M.
  • GRAL
  • Sector
  • ADNT Consumer Discretionary
  • GRAL
  • Exchange
  • ADNT Nasdaq
  • GRAL NYSE
  • Market Cap
  • ADNT 1.6B
  • GRAL 1.6B
  • IPO Year
  • ADNT N/A
  • GRAL N/A
  • Fundamental
  • Price
  • ADNT $22.74
  • GRAL $40.29
  • Analyst Decision
  • ADNT Hold
  • GRAL Buy
  • Analyst Count
  • ADNT 9
  • GRAL 3
  • Target Price
  • ADNT $20.06
  • GRAL $31.50
  • AVG Volume (30 Days)
  • ADNT 1.2M
  • GRAL 1.3M
  • Earning Date
  • ADNT 08-06-2025
  • GRAL 08-12-2025
  • Dividend Yield
  • ADNT N/A
  • GRAL N/A
  • EPS Growth
  • ADNT N/A
  • GRAL N/A
  • EPS
  • ADNT N/A
  • GRAL N/A
  • Revenue
  • ADNT $14,384,000,000.00
  • GRAL $130,711,000.00
  • Revenue This Year
  • ADNT N/A
  • GRAL $20.21
  • Revenue Next Year
  • ADNT N/A
  • GRAL $18.19
  • P/E Ratio
  • ADNT N/A
  • GRAL N/A
  • Revenue Growth
  • ADNT N/A
  • GRAL 30.47
  • 52 Week Low
  • ADNT $10.04
  • GRAL $12.33
  • 52 Week High
  • ADNT $26.59
  • GRAL $63.99
  • Technical
  • Relative Strength Index (RSI)
  • ADNT 66.24
  • GRAL N/A
  • Support Level
  • ADNT $21.58
  • GRAL N/A
  • Resistance Level
  • ADNT $23.25
  • GRAL N/A
  • Average True Range (ATR)
  • ADNT 0.71
  • GRAL 0.00
  • MACD
  • ADNT -0.16
  • GRAL 0.00
  • Stochastic Oscillator
  • ADNT 67.46
  • GRAL 0.00

About ADNT Adient plc

Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion but will likely be below $14 billion in fiscal 2025 on tariff interruptions and divesting some lower-quality business.

About GRAL GRAIL INC

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Share on Social Networks: